DE2248150A1 - Dihydropyridinpolyester, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel - Google Patents

Dihydropyridinpolyester, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Info

Publication number
DE2248150A1
DE2248150A1 DE19722248150 DE2248150A DE2248150A1 DE 2248150 A1 DE2248150 A1 DE 2248150A1 DE 19722248150 DE19722248150 DE 19722248150 DE 2248150 A DE2248150 A DE 2248150A DE 2248150 A1 DE2248150 A1 DE 2248150A1
Authority
DE
Germany
Prior art keywords
given above
meaning given
formula
radical
coor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19722248150
Other languages
German (de)
English (en)
Inventor
Friedrich Dr Bossert
Horst Dr Meyer
Wulf Dr Vater
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Priority to DE19722248150 priority Critical patent/DE2248150A1/de
Priority to US399850A priority patent/US3905983A/en
Priority to CA181,860A priority patent/CA1005061A/en
Priority to IL7343329A priority patent/IL43329A/en
Priority to AU60716/73A priority patent/AU476129B2/en
Priority to DD173732A priority patent/DD110659A5/xx
Priority to HUBA2984A priority patent/HU166357B/hu
Priority to FR7334944A priority patent/FR2201095B1/fr
Priority to CH1390273A priority patent/CH583703A5/xx
Priority to AT834773A priority patent/AT330175B/de
Priority to LU68530A priority patent/LU68530A1/xx
Priority to IE1735/73A priority patent/IE38335B1/xx
Priority to ZA737659*A priority patent/ZA737659B/xx
Priority to GB4548173A priority patent/GB1389509A/en
Priority to DK533473A priority patent/DK137722C/da
Priority to NL7313422A priority patent/NL7313422A/xx
Priority to CH1113776A priority patent/CH605752A5/xx
Priority to BE136158A priority patent/BE805451A/xx
Priority to JP10862773A priority patent/JPS5647905B2/ja
Priority to ES419193A priority patent/ES419193A1/es
Priority to PL1973182553A priority patent/PL92079B1/pl
Priority to PL1973182552A priority patent/PL92084B1/pl
Priority to PL1973165524A priority patent/PL91085B1/pl
Priority to CS5596A priority patent/CS178440B2/cs
Priority to SE7313187A priority patent/SE403777B/xx
Priority to CS6765A priority patent/CS178435B2/cs
Priority to CS5597A priority patent/CS178441B2/cs
Publication of DE2248150A1 publication Critical patent/DE2248150A1/de
Priority to US05/524,090 priority patent/US3946028A/en
Priority to US05/523,982 priority patent/US3943140A/en
Priority to US05/523,967 priority patent/US3946027A/en
Priority to ES443521A priority patent/ES443521A1/es
Priority to ES443522A priority patent/ES443522A1/es
Priority to CH538177A priority patent/CH601233A5/xx
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE19722248150 1972-09-30 1972-09-30 Dihydropyridinpolyester, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel Pending DE2248150A1 (de)

Priority Applications (33)

Application Number Priority Date Filing Date Title
DE19722248150 DE2248150A1 (de) 1972-09-30 1972-09-30 Dihydropyridinpolyester, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US399850A US3905983A (en) 1972-09-30 1973-09-24 3,5,6-Tricarboxy- and 2,3,5,6-tetracarboxy-1,4-dihydropyridine derivatives
CA181,860A CA1005061A (en) 1972-09-30 1973-09-25 Process for the preparation of 3,5,6-tricarboxy-and 2,3,5,6-tetracarboxy-1,4-dihydropyridine derivatives
IL7343329A IL43329A (en) 1972-09-30 1973-09-26 Dihydropyridine-di tri or tetra carboxylates their production and pharmaceutical compositions containing them
AU60716/73A AU476129B2 (en) 1972-09-30 1973-09-26 New dihydropydridine polyesters their production and their medicinal use
DD173732A DD110659A5 (US20100223739A1-20100909-C00025.png) 1972-09-30 1973-09-27
BE136158A BE805451A (fr) 1972-09-30 1973-09-28 Dihydropyridine-polyesters, procede pour leur production et leur application comme medicament
FR7334944A FR2201095B1 (US20100223739A1-20100909-C00025.png) 1972-09-30 1973-09-28
CH1390273A CH583703A5 (US20100223739A1-20100909-C00025.png) 1972-09-30 1973-09-28
AT834773A AT330175B (de) 1972-09-30 1973-09-28 Verfahren zur herstellung von neuen dihydropyridinpolyestern und deren salzen
LU68530A LU68530A1 (US20100223739A1-20100909-C00025.png) 1972-09-30 1973-09-28
IE1735/73A IE38335B1 (en) 1972-09-30 1973-09-28 New dihydropyridine-polyesters their production and their medicinal use
ZA737659*A ZA737659B (en) 1972-09-30 1973-09-28 New dihydropyridine-polyesters their production and their medicinal use
GB4548173A GB1389509A (en) 1972-09-30 1973-09-28 Dihydropyridinepolyesters their production and their medicinal use
DK533473A DK137722C (da) 1972-09-30 1973-09-28 Analogifremgangsmaade til fremstilling af dihydropyridin-polyestere
NL7313422A NL7313422A (US20100223739A1-20100909-C00025.png) 1972-09-30 1973-09-28
CH1113776A CH605752A5 (US20100223739A1-20100909-C00025.png) 1972-09-30 1973-09-28
HUBA2984A HU166357B (US20100223739A1-20100909-C00025.png) 1972-09-30 1973-09-28
JP10862773A JPS5647905B2 (US20100223739A1-20100909-C00025.png) 1972-09-30 1973-09-28
PL1973182552A PL92084B1 (US20100223739A1-20100909-C00025.png) 1972-09-30 1973-09-29
PL1973182553A PL92079B1 (US20100223739A1-20100909-C00025.png) 1972-09-30 1973-09-29
ES419193A ES419193A1 (es) 1972-09-30 1973-09-29 Procedimiento para la obtencion de dihidrofrucidin-polies- teres.
PL1973165524A PL91085B1 (US20100223739A1-20100909-C00025.png) 1972-09-30 1973-09-29
CS5597A CS178441B2 (US20100223739A1-20100909-C00025.png) 1972-09-30 1973-10-01
SE7313187A SE403777B (sv) 1972-09-30 1973-10-01 Sett att framstella nya 1,4-dihydropyridin-polyestrar
CS6765A CS178435B2 (US20100223739A1-20100909-C00025.png) 1972-09-30 1973-10-01
CS5596A CS178440B2 (US20100223739A1-20100909-C00025.png) 1972-09-30 1973-10-01
US05/524,090 US3946028A (en) 1972-09-30 1974-11-15 2,3,5,6-Tetracarboxy-4-pyridyl-1,4-dihydropyridine derivatives
US05/523,982 US3943140A (en) 1972-09-30 1974-11-15 2,3,5,6-Tetracarboxy-1,4-dihydropyridine derivatives
US05/523,967 US3946027A (en) 1972-09-30 1974-11-15 3,5,6-Tricarboxy-4-pyridyl-1,4-dihydropyridine derivatives
ES443521A ES443521A1 (es) 1972-09-30 1975-12-16 Procedimiento para la obtencion de dihidropiridin-polieste- res.
ES443522A ES443522A1 (es) 1972-09-30 1975-12-16 Procedimiento para la obtencion de dihidropiridin-polieste- res.
CH538177A CH601233A5 (US20100223739A1-20100909-C00025.png) 1972-09-30 1977-09-28

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19722248150 DE2248150A1 (de) 1972-09-30 1972-09-30 Dihydropyridinpolyester, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Publications (1)

Publication Number Publication Date
DE2248150A1 true DE2248150A1 (de) 1974-04-04

Family

ID=5857927

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19722248150 Pending DE2248150A1 (de) 1972-09-30 1972-09-30 Dihydropyridinpolyester, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Country Status (22)

Country Link
US (1) US3905983A (US20100223739A1-20100909-C00025.png)
JP (1) JPS5647905B2 (US20100223739A1-20100909-C00025.png)
AT (1) AT330175B (US20100223739A1-20100909-C00025.png)
AU (1) AU476129B2 (US20100223739A1-20100909-C00025.png)
BE (1) BE805451A (US20100223739A1-20100909-C00025.png)
CA (1) CA1005061A (US20100223739A1-20100909-C00025.png)
CH (3) CH605752A5 (US20100223739A1-20100909-C00025.png)
CS (3) CS178441B2 (US20100223739A1-20100909-C00025.png)
DD (1) DD110659A5 (US20100223739A1-20100909-C00025.png)
DE (1) DE2248150A1 (US20100223739A1-20100909-C00025.png)
DK (1) DK137722C (US20100223739A1-20100909-C00025.png)
ES (3) ES419193A1 (US20100223739A1-20100909-C00025.png)
FR (1) FR2201095B1 (US20100223739A1-20100909-C00025.png)
GB (1) GB1389509A (US20100223739A1-20100909-C00025.png)
HU (1) HU166357B (US20100223739A1-20100909-C00025.png)
IE (1) IE38335B1 (US20100223739A1-20100909-C00025.png)
IL (1) IL43329A (US20100223739A1-20100909-C00025.png)
LU (1) LU68530A1 (US20100223739A1-20100909-C00025.png)
NL (1) NL7313422A (US20100223739A1-20100909-C00025.png)
PL (3) PL91085B1 (US20100223739A1-20100909-C00025.png)
SE (1) SE403777B (US20100223739A1-20100909-C00025.png)
ZA (1) ZA737659B (US20100223739A1-20100909-C00025.png)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3970662A (en) * 1975-06-19 1976-07-20 Sterling Drug Inc. 4-(3-Nitrophenyl)-2,3,5,6-pyridinetetracarboxylic acid and intermediates
JPS5223081A (en) * 1975-08-12 1977-02-21 Hexachimie 1*44dihydropyridines and application to remedy
EP0042092A2 (de) * 1980-06-12 1981-12-23 Bayer Ag 1,4-Dihydropyridin-carbonsäureamide Verfahren zu deren Herstellung, ihre Verwendung in Arzneimitteln sowie deren Herstellung
US4338322A (en) * 1975-07-02 1982-07-06 Fujisawa Pharmaceutical Co., Ltd. 1,4-Dihydropyridine derivatives, pharmaceutical compositions containing same and methods of effecting vasodilation using same
US4430333A (en) 1981-03-14 1984-02-07 Pfizer Inc. Dihydropyridine anti-ischaemic and antihypertensive agents
EP0125803A2 (en) * 1983-04-27 1984-11-21 FISONS plc Pharmaceutically active dihydropyridines
US4497808A (en) * 1981-12-30 1985-02-05 Ciba-Geigy Corporation N-Oxide compounds useful in the treatment of cardiovascular ailments
EP0206747A2 (en) 1985-06-17 1986-12-30 Warner-Lambert Company 1,4-Dihydropyridine derivatives useful in the treatment of cardiovascular disorders, and a process for producing the derivatives
US4678796A (en) * 1984-11-30 1987-07-07 Warner-Lambert Company 2-alkylidene derivatives of 1,2,3,4-tetrahydropyridine-2,5-pyridine carboxylic acid dialkyl esters useful for treatment of cardiovascular disorders
US4732898A (en) * 1986-04-29 1988-03-22 Warner-Lambert Company 2-(2-aryl-2-oxoalkylidene) analogs of-3,5-pyridinedicarboxylic acid dialkyl esters useful for treatment of cardiovascular disorders

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK152285C (da) * 1975-07-02 1988-10-10 Fujisawa Pharmaceutical Co Analogifremgangsmaade til fremstilling af 1,4-dihydropyridinderivater
GB1591089A (en) * 1976-12-17 1981-06-10 Fujisawa Pharmaceutical Co 1,4-dihydropyridine derivatives and process for preparation thereof
US4055588A (en) * 1976-02-20 1977-10-25 Sterling Drug Inc. Tetra-(lower-alkyl)3-(3-nitrophenyl)-1,5-pentanedione-1,2,4,5-tetracarboxylates
DE2837477A1 (de) * 1978-08-28 1980-03-13 Bayer Ag Sila-substituierte 1,4-dihydropyridin- derivate
ATE20064T1 (de) * 1982-07-22 1986-06-15 Pfizer Anti-ischaemische und antihypertensive dihydropyridin-derivate.
PH19166A (en) * 1982-09-04 1986-01-16 Pfizer Dihydropyridined,pharmaceutical compositions and method of use
EP0107293A3 (en) * 1982-09-04 1984-06-06 Pfizer Limited Dihydropyridines
US4515799A (en) * 1983-02-02 1985-05-07 Pfizer Inc. Dihydropyridine anti-ischaemic and antihypertensive agents
JPS59144249U (ja) * 1983-03-16 1984-09-27 株式会社御田釦製作所 紐類の端末処理具
DE3629545A1 (de) * 1986-08-30 1988-03-10 Bayer Ag Dihydropyridinverbindungen, verfahren zu ihrer herstellung und ihre verwendung
JPH0688973B2 (ja) * 1987-03-12 1994-11-09 京都薬品工業株式会社 １，４−ジヒドロピリジン誘導体
US6653481B2 (en) * 2000-12-29 2003-11-25 Synthon Bv Process for making amlodipine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2117571C3 (de) * 1971-04-10 1979-10-11 Bayer Ag, 5090 Leverkusen Unsymmetrische 1,4-Dihydropyridin-33-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
DE2117572C3 (de) * 1971-04-10 1980-03-20 Bayer Ag, 5090 Leverkusen Unsymmetrische 1,4-Dihydropyridin ^-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3970662A (en) * 1975-06-19 1976-07-20 Sterling Drug Inc. 4-(3-Nitrophenyl)-2,3,5,6-pyridinetetracarboxylic acid and intermediates
US4338322A (en) * 1975-07-02 1982-07-06 Fujisawa Pharmaceutical Co., Ltd. 1,4-Dihydropyridine derivatives, pharmaceutical compositions containing same and methods of effecting vasodilation using same
JPS5223081A (en) * 1975-08-12 1977-02-21 Hexachimie 1*44dihydropyridines and application to remedy
JPS5422986B2 (US20100223739A1-20100909-C00025.png) * 1975-08-12 1979-08-10
EP0042092A2 (de) * 1980-06-12 1981-12-23 Bayer Ag 1,4-Dihydropyridin-carbonsäureamide Verfahren zu deren Herstellung, ihre Verwendung in Arzneimitteln sowie deren Herstellung
EP0042092A3 (en) * 1980-06-12 1982-07-14 Bayer Ag 1,4-dihydropyridine-4-carboxamides, process for preparing them, their use as medicines and preparation thereof
US4430333A (en) 1981-03-14 1984-02-07 Pfizer Inc. Dihydropyridine anti-ischaemic and antihypertensive agents
US4497808A (en) * 1981-12-30 1985-02-05 Ciba-Geigy Corporation N-Oxide compounds useful in the treatment of cardiovascular ailments
EP0125803A2 (en) * 1983-04-27 1984-11-21 FISONS plc Pharmaceutically active dihydropyridines
EP0125803A3 (en) * 1983-04-27 1987-01-21 FISONS plc Pharmaceutically active dihydropyridines
US4678796A (en) * 1984-11-30 1987-07-07 Warner-Lambert Company 2-alkylidene derivatives of 1,2,3,4-tetrahydropyridine-2,5-pyridine carboxylic acid dialkyl esters useful for treatment of cardiovascular disorders
EP0206747A2 (en) 1985-06-17 1986-12-30 Warner-Lambert Company 1,4-Dihydropyridine derivatives useful in the treatment of cardiovascular disorders, and a process for producing the derivatives
US4732898A (en) * 1986-04-29 1988-03-22 Warner-Lambert Company 2-(2-aryl-2-oxoalkylidene) analogs of-3,5-pyridinedicarboxylic acid dialkyl esters useful for treatment of cardiovascular disorders

Also Published As

Publication number Publication date
ATA834773A (de) 1975-09-15
SE403777B (sv) 1978-09-04
JPS4970977A (US20100223739A1-20100909-C00025.png) 1974-07-09
DD110659A5 (US20100223739A1-20100909-C00025.png) 1974-01-05
BE805451A (fr) 1974-03-28
CS178441B2 (US20100223739A1-20100909-C00025.png) 1977-09-15
CH601233A5 (US20100223739A1-20100909-C00025.png) 1978-06-30
IE38335L (en) 1974-03-30
DK137722B (da) 1978-04-24
IL43329A0 (en) 1973-11-28
PL91085B1 (US20100223739A1-20100909-C00025.png) 1977-02-28
NL7313422A (US20100223739A1-20100909-C00025.png) 1974-04-02
AT330175B (de) 1976-06-25
PL92084B1 (US20100223739A1-20100909-C00025.png) 1977-03-31
JPS5647905B2 (US20100223739A1-20100909-C00025.png) 1981-11-12
ZA737659B (en) 1974-08-28
AU6071673A (en) 1975-03-27
CH583703A5 (US20100223739A1-20100909-C00025.png) 1977-01-14
CS178435B2 (US20100223739A1-20100909-C00025.png) 1977-09-15
ES419193A1 (es) 1976-12-16
CS178440B2 (US20100223739A1-20100909-C00025.png) 1977-09-15
AU476129B2 (en) 1976-09-09
ES443521A1 (es) 1977-05-16
DK137722C (da) 1978-10-02
ES443522A1 (es) 1977-05-01
US3905983A (en) 1975-09-16
IE38335B1 (en) 1978-02-15
HU166357B (US20100223739A1-20100909-C00025.png) 1975-03-28
FR2201095A1 (US20100223739A1-20100909-C00025.png) 1974-04-26
GB1389509A (en) 1975-04-03
CA1005061A (en) 1977-02-08
PL92079B1 (US20100223739A1-20100909-C00025.png) 1977-03-31
CH605752A5 (US20100223739A1-20100909-C00025.png) 1978-10-13
LU68530A1 (US20100223739A1-20100909-C00025.png) 1973-12-10
FR2201095B1 (US20100223739A1-20100909-C00025.png) 1977-09-09
IL43329A (en) 1977-04-29

Similar Documents

Publication Publication Date Title
DE2248150A1 (de) Dihydropyridinpolyester, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2117571C3 (de) Unsymmetrische 1,4-Dihydropyridin-33-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
DE2218644C3 (de) Basische Ester von 1,4-Dihydropyridinen, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
EP0011706B1 (de) Verfahren zur Herstellung von teilweise neuen 1,4-Dihydropyridin-3-carbonsäure-Derivaten (I), neue 1,4-Dihydropyridin-3-carbonsäure-Derivate (II) und die Verwendung der Derivate (I) und (II) zur Herstellung von 1,4-Dihydropyridin-3,5-dicarbonsäurediestern
DE2658183A1 (de) In 2-position substituierte 1,4- dihydropyridin-derivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2210672C3 (de) N-substituierte unsymmetrische 1 ^-Dihydropyridin-S^-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
DE2228363A1 (de) 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2508181A1 (de) 1,4-dihydropyridincarbonsaeurearal- kylester, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2752820A1 (de) Neue nitrosubstituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2847236A1 (de) Neue dihydropyridine mit substituierten estergruppierungen, mehrer verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2117572A1 (de) Unsymmetrische 1,4-Dihydropyridine, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel II
DE2013431B2 (de) 4-Azidophenyl-1,4-dihydropyridin-33-dicarbonsäureester
DE2210633A1 (de) Neue brueckenkopfheterocyclen, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE2335466A1 (de) Alkoxyalkyl-1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2210667A1 (de) Kondensiert aromatisch substituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2117573A1 (de) Verfahren zur Herstellung von neuen unsymmetrischen 1,4-Dihydropyridindicarbonsäureestern, sowie ihre Verwendung als Arzneimittel
EP0009206A2 (de) Fluorhaltige 1,4-Dihydropyridine, diese enthaltende Arzneimittel sowie Verfahren zu ihrer Herstellung
DE2210674A1 (de) Verfahren zur herstellung von neuen 2-amino-1,4-dihydropyridinen sowie ihre verwendung als coronarmittel
DE2228377A1 (de) Dihydropyridin-carbonsaeureamide, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2753946A1 (de) 1-n-aryl-1,4-dihydropyridine und ihre verwendung als arzneimittel
DE2658804A1 (de) Kreislaufbeeinflussende mittel
DE3018259A1 (de) 1,4-dihydropyridine mit unterschiedlichen substituenten in 2- und 6-position, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE2837477A1 (de) Sila-substituierte 1,4-dihydropyridin- derivate
DE2242786A1 (de) Verfahren zur herstellung von neuen 2-amino-1,4-dihydropyridinen mit einer carbonylfunktion sowie ihre verwendung als arzneimittel
DE2239815C2 (de) 2-Alkylamino-dihydropyridine, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel

Legal Events

Date Code Title Description
OD Request for examination
OHN Withdrawal